Michelle Grundahl

Senior Business Development Director @Labcorp Drug Developement

Philadelphia, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Senior Business Development Director @Labcorp Drug Developement

View department →

Business development expertise in preclinical toxicology and drug development; Providing full IND enabling services.

EDUCATION

N/A

George Mason University - Schar School of Policy and Government

Master of Science - MS, Biodefense

1999 — 2003

Delaware Valley University

BS, Animal Science

ABOUT MICHELLE GRUNDAHL

Special interests: One Health, biodefense, counter-terrorism and mass care planning; biothreats, CBRN WMD, bio and agro-terrorism, emergency management, zoonosis, agricultural and food security, public health, veterinary medicine and pharmaceutical drug development. Education: Master of Biodefense from George Mason, Shar School; BS in Animal Biotechnology Volunteer: Co-chair Animal/Mass Care planning for the Philadelphia UASI (South Eastern PA Regional Task Force); Coordinator of animal disaster response in Bucks County PA Member of Pennsylvania\'s One Health Task Force Laboratory experience: Preclinical toxicology laboratory technician/veterinary care (including NHPs). Multiple years of hands-on animal experience (domestic, wildlife, zoo and laboratory: elephant/rhino, monkey, livestock, etc). Drug development: Business Development professional with preclinical toxicology and early clinical trials expertise in contract research (medical countermeasures/pharmaceutical/biotechnology and agro/chemical). COVID19 contact tracer/vaccine clinic (via Medical Reserve Corps)

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Michelle Grundahl — Senior Business Development Director at Labcorp Drug Developement in Philadelphia, PA, US | Unifers